Clearside Biomedical Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
/ 
Frequently asked questions
To buy Clearside Biomedical Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Clearside Biomedical Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Clearside Biomedical Inc. is CLSD:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Clearside Biomedical Inc. has its primary listing on NASDAQ. You can trade Clearside Biomedical Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Clearside Biomedical Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Clearside Biomedical Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Clearside Biomedical Inc..